1 / 8

US Anti-obesity Drugs Market Profiled are Arena Pharmaceuticals, F. Hoffmann-La Roche, GlaxoSmithKline, Novo Nordisk, Or

The analysts forecast anti-obesity drugs market in the US to grow at a CAGR of 24.52% over the period 2014-2019. The report covers the present scenario and the growth prospects of the anti-obesity drugs market in the US for the period 2015-2019.<br>Complete Report Available at http://www.sandlerresearch.org/anti-obesity-drugs-market-in-the-us-2015-2019.html<br>

andreamiller
Download Presentation

US Anti-obesity Drugs Market Profiled are Arena Pharmaceuticals, F. Hoffmann-La Roche, GlaxoSmithKline, Novo Nordisk, Or

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Published : Jul-2015 No. of Pages : 82 (Single User License of the Report is Available at US $2500) Anti-obesity Drugs Market in the US 2015-2019 Reach us at Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org Visit: http://www.sandlerresearch.org

  2. “The analysts forecast anti-obesity drugs market in the US to grow at a CAGR of 24.52% over the period 2014-2019. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.” Special Offer on Technavio/Infiniti Reports Buy 3 reports at the Cost of 2 (Lowest Priced Report will be free)/ Buy 3 Reports of the Same Price for the Cost of 2. Buy 4 or more Reports and get 50% flat discount on the total price. [IMP Note: This Offer Only Valid Via Email To sales@sandlerresearch.org OR Call +1-888-391-5441] Anti-obesity Drugs Market in the US 2015-2019 CAGR Forecast Purchase a Copy at http://www.sandlerresearch.org/purchase?rname=40153

  3. The report covers the present scenario and the growth prospects of the anti-obesity drugs market in the US for the period 2015-2019. • To calculate the market size, the report considers revenue generated from the sales of the currently approved patented drugs, generics, OTC products, and the available generics that are used for the treatment of obesity. • The report, Anti-obesity Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. • The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the • key vendors operating in this market. Anti-obesity Drugs Market in the US 2015-2019 Report Covers Inquire Further on the Report at http://www.sandlerresearch.org/inquire-before-buying?rname=40153

  4. Obesity is a complex multifactorial disorder characterized by the excessive accumulation and storage of fat in the body. In the recent years, this chronic illness is being considered as a global epidemic owing to its strikingly increasing incidence rates, especially in the in low and middle-income countries. Sedentary lifestyles and lack of physical activity coupled with consumption of high-calorie diet are considered to be the most preventable causes of obesity. Being either overweight or obese is considered as a risk factor for the development of multiple chronic diseases including cardiovascular disorders such as coronary heart disease, dyslipidemia, hypertension; metabolic disorders such as diabetes; and cancers to highlight a few. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure. Anti-obesity Drugs Market in the US 2015-2019 About Anti-obesity Drugs Read Full Report at http://www.sandlerresearch.org/anti-obesity-drugs-market-in-the-us-2015-2019.html

  5. Market Driver Growing Prevalence Population • Market Challenge Serious Adverse Events and Multiple Drug Withdrawals • Market Trend Diversification of Investigational Pipeline Anti-obesity Drugs Market in the US 2015-2019 Market Key Components Discount on the Report at http://www.sandlerresearch.org/discount?rname=40153

  6. Arena Pharmaceuticals, F. Hoffmann-La Roche, GlaxoSmithKline, Novo Nordisk, Orexigen Therapeutics and Vivus Anti-obesity Drugs Market in the US 2015-2019 Key Vendors Other Prominent Vendors • Alizyme • Amylin • BoehringerIngelheim • Eisai • Merck • Norgine • Pfizer • Rhythm Pharmaceuticals Order By Fax: http://www.sandlerresearch.org/order-by-fax?rname=40153

  7. What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? NOTE: This Report Is NOT Free Of Charge. Anti-obesity Drugs Market in the US 2015-2019 Key Questions Answered in this Report Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org

  8. About US: Sandlerresearch.org (http://www.sandlerresearch.org/ ) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business. Mail US at: sales@sandlerresearch.org Phone: + 1 888 391 5441 Find US:

More Related